Portfolio Update – Purchase of Cochlear Limited

By November 3, 2021Portfolio
Across investor accounts, we have bought Cochlear Limited (ASX: COH), the global market leader in the provision of implantable hearing solutions.   We are positive on the long-term outlook for COH for the following reasons:
  • It’s estimated that under 5% of people suffering from severe to profound hearing loss have a Cochlear implant, this significant level of under-penetration provides a multi-decade growth opportunity as awareness grows of the recipient and societal benefits;
  • COH’s annual investment in research and development is materially higher than key competitors enabling the business to lead in innovation and product development and maintain its dominant market positioning;
  • The Services business segment, which provides upgrades to existing implant customers, has very high switching costs providing predictable long-term annuity-style revenues;
  • New entrants have regulatory barriers to pass before being able to offer competing products; these barriers create long lead times and provide visibility to existing competitors.
COVID-19 has caused disruption to elective surgeries globally, reducing the number of new Cochlear implants and existing customer services during this period of heightened government imposed restrictions. Despite the disruption, COH remains a high-quality business with a majority share of a large, low penetrated market. Ongoing investment should maintain competitive advantages and market leadership resulting in above GDP revenue growth for several decades.   To fund the acquisition of Cochlear Limited (ASX: COH), we have reduced the weighting in ANZ, Sydney Airport, Westpac and unallocated cash.   As always, thank you for your ongoing support; it is very much appreciated. If you have any questions or would like more information, please contact your SBB Wealth Representative.


WARNINGS AND DISCLOSURES: This material has been prepared for general information purposes only and not as specific advice to any particular person. Any advice contained in this material is General Advice and does not take into account any person’s individual investment objectives, financial situation or needs. Before making an investment decision based on this advice you should consider whether it is appropriate to your particular circumstances, alternatively seek professional advice. Where the General Advice relates to the acquisition or possible acquisition of a financial product, you should obtain a Product Disclosure Statement (“PDS”) relating to the product and consider the PDS before making any decision about whether to acquire the product. You will find further details of the service we provide and any cost to you within the Financial Services Guide. Any references to past investment performance are not an indication of future investment returns. Prepared by EP Financial Service Pty Ltd ABN 52 130 772 495 AFSL 325 252 (“Elston”). Although every effort has been made to verify the accuracy of the information contained in this material, Elston, its officers, representatives, employees and agents disclaim all liability (except for any liability which by law cannot be excluded), for any error, inaccuracy in, or omission from the information contained in this material or any loss or damage suffered by any person directly or indirectly through relying on this information.

Prepared by:
EP Financial Services Pty Ltd
ABN 52 130 772 495 AFSL 325 252 (“ELSTON”)
GPO Box 2220
Brisbane Q 4001